aTyr Pharma (LIFE) Reaches $6.28 52-Week High; Del Taco Restaurants (TACO) Covered By 6 Bullish Analysts Last Week

October 12, 2017 - By Winifred Garcia

The stock of aTyr Pharma Inc (NASDAQ:LIFE) hit a new 52-week high and has $6.78 target or 8.00% above today’s $6.28 share price. The 7 months bullish chart indicates low risk for the $186.62 million company. The 1-year high was reported on Oct, 12 by Barchart.com. If the $6.78 price target is reached, the company will be worth $14.93 million more. About 35,651 shares traded. aTyr Pharma Inc (NASDAQ:LIFE) has risen 12.96% since October 12, 2016 and is uptrending. It has underperformed by 3.74% the S&P500.

Among 7 analysts covering Del Taco (NASDAQ:TACO), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Del Taco had 14 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Wedbush on Tuesday, May 3. The firm has “Buy” rating given on Tuesday, September 8 by Citigroup. The rating was initiated by Dougherty & Company on Tuesday, October 13 with “Buy”. The firm has “Buy” rating by Wedbush given on Friday, July 28. The rating was maintained by Maxim Group on Thursday, June 22 with “Buy”. As per Wednesday, October 28, the company rating was initiated by Piper Jaffray. The stock has “Hold” rating by Piper Jaffray on Monday, July 24. Jefferies maintained the stock with “Buy” rating in Thursday, July 27 report. Jefferies initiated it with “Buy” rating and $16 target in Tuesday, November 3 report. Wedbush maintained the stock with “Buy” rating in Thursday, July 20 report. See Del Taco Restaurants Inc (NASDAQ:TACO) latest ratings:

27/07/2017 Broker: Jefferies Rating: Buy New Target: $16.0000 Maintain
28/07/2017 Broker: Wedbush Rating: Buy Maintain
24/07/2017 Broker: Piper Jaffray Rating: Hold New Target: $13.0000 Maintain
20/07/2017 Broker: Wedbush Rating: Buy Maintain
22/06/2017 Broker: Maxim Group Rating: Buy New Target: $19.0000 Maintain
13/06/2017 Broker: Jefferies Rating: Buy New Target: $16.0000 Maintain

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The company has market cap of $186.62 million. The Firm is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. It currently has negative earnings. The Firm focuses on the development of Physiocrine therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy and limb-girdle muscular dystrophy (LGMD) 2B.

Among 6 analysts covering Life Technologies Corp (NASDAQ:LIFE), 1 have Buy rating, 1 Sell and 4 Hold. Therefore 17% are positive. Life Technologies Corp has $10 highest and $400 lowest target. $6.25’s average target is -0.48% below currents $6.28 stock price. Life Technologies Corp had 9 analyst reports since August 25, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, August 16 by Citigroup. The firm has “Market Perform” rating given on Thursday, March 31 by William Blair. The rating was initiated by Citigroup with “Neutral” on Wednesday, December 16. The company was downgraded on Thursday, September 17 by Zacks. As per Wednesday, December 14, the company rating was downgraded by JP Morgan. The rating was downgraded by Zacks on Tuesday, August 25 to “Hold”. The firm has “Buy” rating given on Thursday, September 7 by Piper Jaffray. The firm has “Hold” rating by BMO Capital Markets given on Monday, August 14. On Thursday, August 11 the stock rating was maintained by JP Morgan with “Overweight”.

Analysts await aTyr Pharma Inc (NASDAQ:LIFE) to report earnings on November, 13. They expect $-0.52 earnings per share, up 10.34% or $0.06 from last year’s $-0.58 per share. After $-0.51 actual earnings per share reported by aTyr Pharma Inc for the previous quarter, Wall Street now forecasts 1.96% negative EPS growth.

About 26,545 shares traded. Del Taco Restaurants Inc (NASDAQ:TACO) has risen 44.12% since October 12, 2016 and is uptrending. It has outperformed by 27.42% the S&P500.

Del Taco Restaurants, Inc. is an operator and franchisor of restaurants featuring made-to-order cuisine, including both Mexican inspired and American classic dishes. The company has market cap of $590.74 million. As of January 3, 2017, the Company operated 551 Del Taco restaurants. It has a 27.14 P/E ratio. The Company’s menu offers a combination of Mexican-inspired food, such as tacos and burritos, and American classics, such as Double Del cheeseburgers, crinkle-cut fries and milkshakes.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com